General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 591: Histopathologically, what is the definition of an abscess?

A. A localized collection of purulent material with necrotic cells, surrounded by inflamed tissue. (Correct Answer)
B. An infection involving the dermis and subcutaneous fat.
C. Necrosis caused by critically insufficient blood supply resulting in cell death.
D. An abnormal pattern of tissue growth with invasion.

Explanation: ### Explanation **Correct Option: A (A localized collection of purulent material with necrotic cells, surrounded by inflamed tissue)** An abscess is a localized manifestation of **acute suppurative inflammation** [2]. Pathologically, it is characterized by a central mass of "pus" (neutrophils, necrotic cells, and edema fluid) surrounded by a zone of preserved neutrophils, dilated vessels, and fibroblastic proliferation (the pyogenic membrane) [1,4]. This process is typically triggered by pyogenic bacteria (e.g., *Staphylococcus aureus*) which cause **liquefactive necrosis**, the hallmark of abscess formation [4]. **Analysis of Incorrect Options:** * **Option B:** This describes **Cellulitis**. Unlike an abscess, cellulitis is a spreading, non-circumscribed infection of the skin and subcutaneous tissues, often caused by *Streptococcus pyogenes* (via hyaluronidase production). * **Option C:** This describes **Gangrene** (specifically dry gangrene). Gangrene is a form of coagulative necrosis resulting from ischemia, often seen in limbs [3]. * **Option D:** This describes **Malignancy/Neoplasia**. Abnormal growth with invasion is characteristic of malignant tumors, not an acute inflammatory process. **High-Yield Facts for NEET-PG:** * **Necrosis Type:** Abscesses are the classic example of **liquefactive necrosis** (except in the brain, where most infarcts are liquefactive). * **Key Mediator:** Neutrophils are the primary cells; they release lysosomal enzymes that digest the tissue, creating the liquid center [1]. * **Outcome:** If not drained, an abscess may become walled off by fibrous tissue, leading to a chronic abscess or "cold abscess" (classically seen in Tuberculosis). * **Clinical Pearl:** The "pyogenic membrane" is the body's attempt to wall off the infection, but it also limits the penetration of systemic antibiotics, often necessitating surgical incision and drainage (I&D) [4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 192-193. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, p. 360. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 191-192. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 193-194.

Question 592: Which of the following is an Autosomal Dominant condition?

A. Albinism
B. Huntington's chorea
C. Hurler's syndrome
D. Hunter's syndrome (Correct Answer)

Explanation: **Explanation:** The question asks for an Autosomal Dominant (AD) condition. However, there is a significant discrepancy in the provided key: **Hunter’s syndrome is actually X-linked Recessive (XLR)**, not Autosomal Dominant. Among the options provided, **Huntington’s chorea** is the classic example of an Autosomal Dominant disorder [1]. **Analysis of Options:** * **Huntington’s Chorea (Option B):** This is a classic **Autosomal Dominant** neurodegenerative disorder characterized by "Anticipation" due to CAG trinucleotide repeats on Chromosome 4 [1]. It presents with chorea, dementia, and psychiatric symptoms. * **Hunter’s Syndrome (Option D - Marked Correct):** This is an **X-linked Recessive** Mucopolysaccharidosis (MPS Type II) caused by a deficiency of Iduronate-2-sulfatase. It is unique among MPS because it lacks corneal clouding. * **Albinism (Option A):** Most forms (Oculocutaneous Albinism) are **Autosomal Recessive**. * **Hurler’s Syndrome (Option C):** This is **Autosomal Recessive** (MPS Type I) caused by Alpha-L-iduronidase deficiency. Unlike Hunter’s, it features prominent corneal clouding. **High-Yield NEET-PG Pearls:** 1. **Hunter vs. Hurler:** "The Hunter needs clear eyes to see the X" (Hunter is **X**-linked and has **no** corneal clouding). 2. **AD Disorders:** Usually involve structural proteins (e.g., Marfan, Osteogenesis Imperfecta) or gain-of-function mutations (e.g., Huntington’s) [1]. 3. **AR Disorders:** Usually involve enzyme deficiencies (e.g., Albinism, most Lysosomal Storage Diseases). 4. **Trinucleotide Repeats:** Huntington’s (CAG), Fragile X (CGG), Myotonic Dystrophy (CTG), and Friedreich Ataxia (GAA) [1]. *Note: If this question appeared in an exam with this specific key, it represents a technical error in the source material, as Huntington's is the only AD condition listed.* **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 148-150, 177-179.

Question 593: A 12-year-old boy is rescued 2 days after becoming lost in the woods in February. Physical examination shows he has gangrene of his fingers and toes. Which of the following mechanisms of cell injury played the most important role in mediating necrosis in the fingers and toes of this patient?

A. Activation of proapoptotic proteins
B. Generation of activated oxygen species
C. Lipid peroxidation
D. Membrane disruption by water crystals (Correct Answer)

Explanation: **Explanation:** The clinical scenario describes **frostbite**, a form of physical cell injury caused by extreme cold. When tissues are exposed to freezing temperatures (as seen in this boy lost in February), the primary mechanism of injury is the formation of **ice crystals**. [1] **1. Why the Correct Answer is Right:** In frostbite, ice crystals form in the extracellular and intracellular spaces. These **water crystals** act as physical daggers, causing direct **mechanical disruption of the cell membrane**. Additionally, as water freezes, the remaining extracellular fluid becomes hypertonic, drawing water out of the cells (osmotic dehydration), which further leads to electrolyte imbalances and cell death (necrosis). **2. Why the Incorrect Options are Wrong:** * **Activation of proapoptotic proteins (A):** This is the mechanism for *Apoptosis* (programmed cell death). [3] Frostbite causes *Necrosis*, which is an uncontrolled, accidental cell death characterized by membrane rupture and inflammation. [4] * **Generation of activated oxygen species (B) & Lipid peroxidation (C):** These are hallmarks of **Free Radical Injury** (e.g., reperfusion injury, radiation, or chemical toxicity). While oxidative stress may occur during rewarming, the *initial and most important* cause of necrosis in freezing is the physical trauma from ice crystals. **Clinical Pearls for NEET-PG:** * **Physical Agents of Injury:** Remember that cold causes injury via two phases: the **Direct phase** (ice crystal formation) and the **Indirect phase** (vasoconstriction and endothelial damage leading to ischemia/gangrene). [1] * **High-Yield Association:** While cold causes membrane disruption by ice, **Heat** causes injury primarily through the **denaturation of proteins**. [2] * **Morphology:** Frostbite typically leads to **Coagulative Necrosis**, which may progress to **Dry Gangrene** if the blood supply is severely compromised. [4] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 435-436. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 99-100. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 60-61. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 53-55.

Question 594: Karyotyping is done for which type of disorders?

A. Chromosomal disorders (Correct Answer)
B. Autosomal recessive disorders
C. Autosomal dominant disorders
D. Linkage disorders

Explanation: **Explanation:** **Karyotyping** is a cytogenetic technique used to examine the complete set of chromosomes in a cell [1]. It involves arresting cells in **metaphase** (using colchicine), staining them (usually G-banding), and arranging them by size, centromere position, and banding pattern [2]. 1. **Why Option A is Correct:** Karyotyping is specifically designed to detect **chromosomal disorders**, which involve large-scale structural or numerical abnormalities [2]. It can identify **aneuploidies** (e.g., Trisomy 21 in Down Syndrome, 45,X in Turner Syndrome) and **large structural rearrangements** like translocations (e.g., t(9;22) in CML), deletions, or inversions that are visible under a light microscope (typically >5-10 Mb) [1]. 2. **Why Other Options are Incorrect:** * **Options B & C (Autosomal Recessive/Dominant):** These are **Mendelian (single-gene) disorders** caused by point mutations, small insertions, or deletions within a specific DNA sequence. These changes are too microscopic to be seen on a karyotype and require molecular techniques like **PCR** or **DNA sequencing**. * **Option D (Linkage Disorders):** Linkage refers to the tendency of genes located close together on the same chromosome to be inherited together. Studying linkage requires **pedigree analysis** or **SNP microarrays**, not visual chromosome mapping. **High-Yield Clinical Pearls for NEET-PG:** * **Sample Source:** Peripheral blood (T-lymphocytes) is most common. Phytohemagglutinin (PHA) is added to stimulate mitosis. * **Resolution:** Standard karyotyping cannot detect **microdeletions** (e.g., DiGeorge Syndrome); for these, **FISH** (Fluorescence In Situ Hybridization) is the gold standard. * **Indication:** Common indications include suspected trisomies, recurrent spontaneous abortions, and ambiguous genitalia [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 167-171. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 54-55.

Question 595: Which one of the following is a pan T lymphocyte marker?

A. CD2
B. CD3 (Correct Answer)
C. CD19
D. CD25

Explanation: **Explanation:** The correct answer is **CD3**. In pathology and immunology, CD3 is considered the definitive **pan-T cell marker** because it is physically associated with the T-cell receptor (TCR) [1], [2], [4]. It is expressed on the surface of all mature T lymphocytes and is essential for signal transduction [1], [2]. In clinical practice, CD3 is the most reliable immunohistochemical (IHC) marker used to identify T-cell lineages in lymphomas. **Analysis of Options:** * **CD2 (Option A):** While CD2 is expressed on T cells and Natural Killer (NK) cells, it is primarily an adhesion molecule (LFA-2). It is not as specific as CD3 for T-cell identification. * **CD19 (Option B):** This is a classic **pan-B cell marker** [1], [3]. It is expressed throughout B-cell development (from pro-B cells to mature B cells) but is lost during differentiation into plasma cells [1]. * **CD25 (Option C):** This is the alpha chain of the IL-2 receptor. It is an **activation marker** found on activated T cells, B cells, and is constitutively expressed on Regulatory T cells (Tregs). It is not present on all resting T cells. **High-Yield Clinical Pearls for NEET-PG:** * **Pan-T markers:** CD3 (most specific), CD2, CD5, and CD7 [1]. * **Pan-B markers:** CD19, CD20 (target of Rituximab), and CD79a [1], [3]. * **NK Cell markers:** CD16 and CD56. * **Reed-Sternberg Cells (Hodgkin Lymphoma):** Characteristically CD15+ and CD30+. * **Flow Cytometry Tip:** CD3 is the first marker looked at to categorize a lymphoid population as T-cell in origin. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 598. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 198-199. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 199-200. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 156-157.

Question 596: What is the best method for confirming a diagnosis of amyloidosis?

A. Colonoscopy
B. Sigmoidoscopy
C. Rectal biopsy (Correct Answer)
D. Tongue biopsy

Explanation: **Explanation:** The diagnosis of amyloidosis depends on the histological demonstration of amyloid deposits in tissues. Amyloid is an extracellular proteinaceous material [1] that shows characteristic **apple-green birefringence** under polarized light when stained with **Congo red** [1]. **Why Rectal Biopsy is the Correct Answer:** Historically and traditionally, **rectal biopsy** has been considered the "gold standard" for confirming systemic amyloidosis due to its high diagnostic yield (approximately 75–80%). The submucosal vessels of the rectum are frequently involved in systemic amyloidosis, making it a reliable site for obtaining a tissue sample. While **Abdominal Fat Pad Aspiration** is now often the preferred initial screening test due to its non-invasive nature, rectal biopsy remains the most definitive "best" classic method among the provided options for confirming the diagnosis. **Analysis of Incorrect Options:** * **A & B (Colonoscopy/Sigmoidoscopy):** These are endoscopic procedures used to visualize the bowel. While they are used to perform a biopsy, the procedure itself is not the diagnostic test. Furthermore, a full colonoscopy is unnecessarily invasive for the sole purpose of diagnosing amyloidosis. * **D (Tongue Biopsy):** Although the tongue is a common site for localized amyloid deposition (macroglossia) [1], a biopsy here is painful, carries a risk of significant bleeding, and has a lower diagnostic yield for systemic involvement compared to rectal or fat pad biopsies. **High-Yield NEET-PG Pearls:** * **Most common screening test:** Fine Needle Aspiration (FNA) of Abdominal Fat Pad (Yield ~70-80%). * **Most sensitive organ biopsy:** Renal biopsy (Yield >90%), but it carries a higher risk of bleeding. * **Stain of choice:** Congo Red (shows pink-red color under light microscopy) [1]. * **Pathognomonic finding:** Apple-green birefringence under polarized light [1]. * **Electron Microscopy:** Shows non-branching, linear fibrils (7.5–10 nm diameter) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-270.

Question 597: Amyloid (AA) originates from which cell type?

A. RBC
B. Plasma cell
C. Reticulo-endothelial cell (Correct Answer)
D. Lymphocytes

Explanation: **Explanation:** Amyloidosis involves the extracellular deposition of misfolded proteins [3]. **Amyloid Associated (AA) protein** is derived from a precursor called **Serum Amyloid A (SAA)**, an acute-phase reactant synthesized primarily by the liver during chronic inflammation [1]. 1. **Why Option C is Correct:** The synthesis of AA amyloid is a two-step process. First, SAA is produced by hepatocytes in response to cytokines (IL-1, IL-6, and TNF) [1]. Second, this SAA protein is taken up and proteolytically cleaved by **reticulo-endothelial cells** (specifically macrophages) [2]. These cells possess the enzymes necessary to break down SAA into the smaller AA amyloid fibrils, which are then deposited in tissues [2]. 2. **Why Other Options are Incorrect:** * **Option A (RBC):** Red blood cells are involved in oxygen transport and do not participate in protein synthesis or the pathogenesis of amyloidosis. * **Option B (Plasma Cells):** These cells are responsible for **AL (Amyloid Light Chain)** amyloid, seen in Multiple Myeloma [4]. AL amyloid is derived from immunoglobulin light chains, not AA. * **Option D (Lymphocytes):** While lymphocytes secrete cytokines that stimulate the liver to produce SAA, they do not directly synthesize or process the AA amyloid fibrils [1]. **High-Yield Clinical Pearls for NEET-PG:** * **AA Amyloidosis** is associated with **chronic inflammatory conditions** (e.g., Rheumatoid Arthritis, Bronchiectasis, Osteomyelitis) and **Familial Mediterranean Fever (FMF)** [1], [2]. * **Staining:** All amyloids show **apple-green birefringence** under polarized light after **Congo Red** staining [5]. * **Morphology:** On H&E stain, amyloid appears as an extracellular, amorphous, eosinophilic (pink) hyaline material [5]. * **Precursor Summary:** AL (Plasma cells/B-cells), AA (Liver/Macrophages), ATTR (Transthyretin), A̠ (Amyloid Precursor Protein in Alzheimer’s). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 267-268. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 268-269.

Question 598: Testing of recipient cells against donor serum is:

A. Major Cross Matching
B. Minor Crossmatching (Correct Answer)
C. Direct Coomb's Test
D. Rh Group Matching

Explanation: ### Explanation In blood transfusion medicine, **cross-matching** is performed to ensure compatibility between the donor and the recipient beyond simple ABO/Rh typing. **1. Why "Minor Crossmatching" is correct:** Cross-matching is categorized into two types based on what is being tested: * **Major Cross-match:** Donor’s Red Blood Cells (RBCs) + Recipient’s Serum. This is the most critical step as it detects if the recipient has antibodies against the donor's cells (which could cause a fatal hemolytic reaction) [2]. * **Minor Cross-match:** **Recipient’s RBCs + Donor’s Serum.** This tests if the donor’s serum contains antibodies against the recipient’s antigens. In modern practice, minor cross-matching is often bypassed if the donor unit is screened for atypical antibodies, but it remains the correct definition for this laboratory procedure. **2. Why other options are incorrect:** * **Option A (Major Cross-match):** This involves testing **Donor cells against Recipient serum**. It is the "major" concern because the recipient's entire blood volume is available to attack the small volume of transfused donor cells [2]. * **Option C (Direct Coombs Test):** This is used to detect antibodies or complement proteins already bound to the surface of RBCs *in vivo* (e.g., in Autoimmune Hemolytic Anemia or Hemolytic Disease of the Newborn). * **Option D (Rh Group Matching):** This is a preliminary step of blood grouping (checking for the D antigen) performed before cross-matching, not a test of cells against serum [1]. **3. Clinical Pearls for NEET-PG:** * **Golden Rule:** Major = Donor Cells + Recipient Serum; Minor = Recipient Cells + Donor Serum. * **Saline Phase:** Detects IgM antibodies (e.g., ABO incompatibility). * **AHG (Coombs) Phase:** Detects IgG antibodies (e.g., Rh, Kell, Duffy). * **Emergency Transfusion:** If there is no time for cross-matching, **O-negative** uncross-matched packed RBCs are used. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 627-628. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 673-674.

Question 599: Necrotizing arteritis with fibrinoid necrosis is mediated by which of the following mechanisms?

A. Immediate hypersensitivity
B. Cell-mediated hypersensitivity
C. Antigen-antibody complex mediated hypersensitivity (Correct Answer)
D. Cytotoxic cell-mediated hypersensitivity

Explanation: **Explanation:** **1. Why Option C is Correct:** Necrotizing arteritis with **fibrinoid necrosis** is the hallmark of **Type III Hypersensitivity (Immune Complex-Mediated)** [1]. In this mechanism, antigen-antibody complexes are deposited in the vascular walls. These complexes activate the **classical complement pathway**, leading to the recruitment of neutrophils [2]. Neutrophils release lysosomal enzymes and reactive oxygen species that damage the vessel wall [1]. The leakage of plasma proteins (including fibrin) into the damaged wall, combined with cellular debris, creates the bright pink, amorphous appearance known as "fibrinoid necrosis" under light microscopy. **2. Why Other Options are Incorrect:** * **Option A (Immediate Hypersensitivity):** Type I hypersensitivity is mediated by IgE and mast cell degranulation (e.g., anaphylaxis, asthma). It does not typically cause necrotizing vasculitis. * **Option B & D (Cell-Mediated/Cytotoxic Hypersensitivity):** Type IV hypersensitivity involves T-cells and macrophages. While it can cause granulomatous inflammation (e.g., Giant Cell Arteritis), it is not the primary mechanism for acute fibrinoid necrotizing arteritis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Classic Examples:** Polyarteritis Nodosa (PAN) and Systemic Lupus Erythematosus (SLE) are classic examples of Type III hypersensitivity causing fibrinoid necrosis [4]. * **Morphology:** On H&E stain, fibrinoid necrosis appears as an **eosinophilic (smudgy pink)** circumferential area in the arterial wall. * **Arthus Reaction:** A localized form of Type III hypersensitivity that specifically demonstrates necrotizing vasculitis [2]. * **Exception:** Note that ANCA-associated vasculitides (like GPA) are "pauci-immune," meaning they show necrosis but minimal actual immune complex deposition on immunofluorescence [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 214-215. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 172-173. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Cardiovascular Disease, pp. 278-279. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 215-216.

Question 600: What is the first cellular change observed in hypoxia?

A. Decreased oxidative phosphorylation in mitochondria (Correct Answer)
B. Cellular swelling
C. Alteration in cellular membrane permeability
D. Clumping of nuclear chromatin

Explanation: **Explanation:** **Why Option A is correct:** Hypoxia is defined as a deficiency of oxygen, which is the terminal electron acceptor in the mitochondrial respiratory chain. The **earliest biochemical consequence** of hypoxia is the failure of aerobic respiration [1]. This leads to a rapid **decrease in oxidative phosphorylation** within the mitochondria, resulting in a significant drop in Adenosine Triphosphate (ATP) production [2]. This failure of ATP synthesis is the "trigger" that initiates all subsequent morphological and functional changes in the cell. **Why other options are incorrect:** * **Option B (Cellular swelling):** This is the first **morphological (microscopic)** sign of cell injury, but it occurs *after* the failure of the Na+/K+ ATPase pump, which itself is caused by the initial drop in ATP [1]. * **Option C (Alteration in membrane permeability):** While membrane damage occurs due to lipid peroxidation and cytoskeleton breakdown, it is a downstream effect of ATP depletion and calcium influx, not the initial event. * **Option D (Clumping of nuclear chromatin):** This occurs due to a decrease in intracellular pH (lactic acidosis) resulting from compensatory anaerobic glycolysis. It is a later reversible change compared to the immediate cessation of oxidative phosphorylation. **NEET-PG High-Yield Pearls:** * **Sequence of events:** Hypoxia → ↓ Oxidative Phosphorylation → ↓ ATP → Failure of Na+/K+ Pump → Influx of Na+ and Water → **Cellular Swelling (Hydropic change).** * **Point of Irreversibility:** Severe **mitochondrial damage** (inability to restore ATP) and **membrane damage** (lysosomal and plasma membrane) mark the transition from reversible to irreversible injury. * **First sign of cell death:** The earliest sign of irreversible injury/necrosis visible under a light microscope is nuclear changes (Pyknosis). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 49-50. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 56-57.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free